WILMINGTON, Del., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Barclays Global Healthcare Conference in Miami, March 12-14, 2024.
Read more at globenewswire.comPrelude Therapeutics to Participate in Barclays Global Healthcare Conference
PRELUDE THERAPEUTICS INC
NASDAQ:PRLD (2/11/2025, 3:07:50 PM)
0.9255
-0.16 (-15.09%)
PRLD Latest News and Analysis
a day ago - ChartmillStay updated with the stocks that are on the move in today's after-hours session.Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
